Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 3/20 | 0.58 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | TUBB4A | P04350 | 5/20 | 0.50 |
| ▸ | TUBB | P07437 | 5/20 | 0.50 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.50 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.50 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.50 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.50 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.50 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.50 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.50 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.50 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.50 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.50 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 0.50 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 0.50 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 0.50 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.49 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.49 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670946 | 0.91 | ENPP2 (0.71) | ENPP2IDO1PRKAG1PRKAA2PRKAB1 | |
| SCHEMBL671569 | 0.86 | MAPT (0.56) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL670454 | 0.81 | PRKAG1 (0.50) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL15024212 | 0.80 | ENPP2 (0.53) | ENPP2PRKAG1PRKAA2PRKAB1MAPT | |
| SCHEMBL670395 | 0.80 | ENPP2 (0.53) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL672811 | 0.79 | ENPP2 (0.62) | ENPP2MAPTMEN1KMT2A | |
| SCHEMBL671752 | 0.78 | ENPP2 (0.51) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL670975 | 0.78 | ENPP2 (0.61) | ENPP2AKR1B1PTGDR2 | |
| SCHEMBL671414 | 0.77 | ENPP2 (0.60) | ENPP2MAPTKDM4EMEN1ALDH1A1 | |
| SCHEMBL672043 | 0.77 | PRKAG1 (0.43) | ENPP2TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103201262-B | Autotaxin inhibitors and application thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2016-06-01 | — | — | CN | claimed |
| US-9000025-B2 | Autotaxin inhibitors and uses thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2015-04-07 | — | — | US | claimed |
| EP-2606031-A2 | AUTOTAXIN INHIBITORS AND USES THEREOF | Amira Pharmaceuticals, Inc. (US) | 2013-06-26 | — | — | EP | claimed |
| US-20130150326-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2013-06-13 | — | — | US | claimed |
| WO-2012024620-A2 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2012-02-23 | — | — | WO | claimed |
| US-9849109-B2 | Autotaxin inhibitors and uses thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-9849109-B2 | Autotaxin inhibitors and uses thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-9849109-B2 | Autotaxin inhibitors and uses thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| EP-2606031-B1 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS INC (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-2606031-B1 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS INC (US) | 2017-09-27 | — | — | EP | disclosed |
| CN-103201262-B | Autotaxin inhibitors and application thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2016-06-01 | — | — | CN | disclosed |
| US-20150164861-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2015-06-18 | — | — | US | disclosed |
| US-9000025-B2 | Autotaxin inhibitors and uses thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2015-04-07 | — | — | US | disclosed |
| US-9000025-B2 | Autotaxin inhibitors and uses thereof | AMIRA PHARMACEUTICALS, INC. (US) | 2015-04-07 | — | — | US | disclosed |
| EP-2606031-A2 | AUTOTAXIN INHIBITORS AND USES THEREOF | Amira Pharmaceuticals, Inc. (US) | 2013-06-26 | — | — | EP | disclosed |
| US-20130150326-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2013-06-13 | — | — | US | disclosed |
| US-20130150326-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2013-06-13 | — | — | US | disclosed |
| US-20130150326-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2013-06-13 | — | — | US | disclosed |
| WO-2012024620-A2 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2012-02-23 | — | — | WO | disclosed |
| WO-2012024620-A2 | AUTOTAXIN INHIBITORS AND USES THEREOF | AMIRA PHARMACEUTICALS, INC. (US) | 2012-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130150326-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | ENPP2, SERPINB1, SERPINE1 | ENPP2 1/4885IDO1 1700/4885TUBB4A 1404/4885 |
| US-20150164861-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | ENPP2, SERPINB1, SERPINE1 | ENPP2 1/4885IDO1 1700/4885TUBB4A 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.